Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients

Clinical trial NCT06389695 · COMPLETED

Trial details

NCT number: NCT06389695
Sponsor: Norroy Bioscience Co., LTD
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2024-06-04
Primary completion: 2024-10-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.